Has Crestchem declared dividend?

Crestchem Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of August 23, 2024. The dividend yield is 0.3%, and while the company has shown significant price appreciation over the years, the total returns vary across different periods.

Crestchem Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 23 Aug 24<BR><BR>Dividend Yield: 0.3%.<BR><BR>Total Returns by Period:<BR>Over the 6-month period, Crestchem experienced a price return of -39.7%, with no dividend return, resulting in a total return of -39.7%.<BR><BR>In the 1-year period, the price return was 26.84%, with a dividend return of 0.37%, leading to a total return of 27.21%.<BR><BR>For the 2-year period, the price return was 84.46%, with a dividend return of 0.68%, resulting in a total return of 85.14%.<BR><BR>During the 3-year period, the price return was 243.46%, with a dividend return of 1.12%, culminating in a total return of 244.58%.<BR><BR>In the 4-year period, the price return was 328.42%, with a dividend return of 1.10%, leading to a total return of 329.52%.<BR><BR>Over the 5-year period, Crestchem saw a remarkable price return of 1450.48%, with a dividend return of 4.76%, resulting in a total return of 1455.24%.<BR><BR>Overall, Crestchem has declared a dividend while also showing varying total returns over different periods, with significant growth in price returns, particularly over the longer term. The dividend yield remains relatively low compared to the substantial price appreciation.

Who are the peers of the Crestchem?

Crestchem's peers include Pidilite Industries, SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Hardcast & Waud, Seya Industries, Yug Decor, and Vikram Aroma. Crestchem has good management risk and growth, with a 1-year return of 31.30%, while Himadri Special leads with 41.42% return, and Seya Industries has the lowest at -22.50%.

Peers: The peers of Crestchem are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Hardcast.& Waud, Seya Industries, Yug Decor, Vikram Aroma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, Pidilite Inds., and SRF, while Good management risk is found at Crestchem and Yug Decor. Average management risk is present at Himadri Special and Gujarat Fluoroch, and Below Average management risk is noted for Hardcast.& Waud, Seya Industries, and Vikram Aroma. Growth is Good at Crestchem and Himadri Special, Average at Pidilite Inds. and SRF, Below Average at Gujarat Fluoroch, Deepak Nitrite, Hardcast.& Waud, Seya Industries, and Vikram Aroma, and the rest have varying ratings. Capital Structure is Excellent at Pidilite Inds. and Deepak Nitrite, Good at Gujarat Fluoroch, Himadri Special, Crestchem, and Vikram Aroma, and Below Average at Seya Industries.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Himadri Special at 41.42%, while the lowest is Seya Industries at -22.50%. Crestchem's 1-year return of 31.30% is higher than Seya Industries but lower than Himadri Special. Additionally, several peers, including Deepak Nitrite, Hardcast.& Waud, Seya Industries, and Vikram Aroma, have negative six-month returns.

What is the technical trend for Crestchem?

As of June 2, 2025, Crestchem's technical trend has shifted to bearish, supported by a weak weekly MACD, bearish Bollinger Bands, and significant recent declines of -9.24% over one week and -15.63% over one month, despite a contrasting bullish monthly KST.

As of 2 June 2025, the technical trend for Crestchem has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly MACD is bearish, and Bollinger Bands are also signaling bearish conditions. Daily moving averages confirm the bearish trend. While the monthly KST is bullish, it contrasts with the bearish signals from other indicators. The stock has seen significant declines recently, with a 1-week return of -9.24% and a 1-month return of -15.63%, further supporting the bearish outlook.

Who are in the management team of Crestchem?

As of March 2023, the management team of Crestchem includes Dipak N Patel (Chairman & Managing Director), Khyati Dipakkumar Vyas (CFO & Company Secretary), and several non-executive and independent directors: Rajesh I Mody, Binaben Parasbhai Patel, Nitin Shantilal Shah, and Manojkumar Babubhai Patel, along with Executive Director Nirmit Dipak Patel.

As of March 2023, the management team of Crestchem includes the following members:<BR><BR>1. Dipak N Patel - Chairman & Managing Director<BR>2. Rajesh I Mody - Non-Executive & Independent Director<BR>3. Binaben Parasbhai Patel - Non-Executive & Independent Director<BR>4. Nitin Shantilal Shah - Non-Executive & Independent Director<BR>5. Khyati Dipakkumar Vyas - CFO & Company Secretary<BR>6. Manojkumar Babubhai Patel - Independent Director<BR>7. Nirmit Dipak Patel - Executive Director<BR><BR>These individuals play key roles in the governance and management of the company.

What does Crestchem do?

Crestchem Ltd is a micro-cap company specializing in the processing, manufacturing, trading, and marketing of specialty chemical ingredients. As of March 2025, it reported net sales of 72 Cr and a net profit of 6 Cr.

Overview:<BR>Crestchem Ltd is engaged in the processing, manufacturing, trading, and marketing of specialty chemical ingredients, operating within the specialty chemicals industry and classified as a micro-cap company.<BR><BR>History:<BR>Crestchem Limited was incorporated in April 1991. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 72 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 6 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 50 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 19.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.30% <BR>Debt Equity: -0.10 <BR>Return on Equity: 36.50% <BR>Price to Book: 6.73 <BR><BR>Contact Details:<BR>Address: Sr No 550/1 Sub Plot No 12, Village-Indrad Taluka Kadi Mehsana Gujarat : 382715 <BR>Tel: 91-2764-278247/09409119484 <BR>Email: info@crestchemlimited.in/investor@c <BR>Website: http://www.crestchemlimited.in

Who are the top shareholders of the Crestchem?

The top shareholder of Crestchem is Mr. Dipak Narendraprasad Patel, with a 28.94% stake. Individual investors hold 66.63% of the shares, with no institutional holdings or pledged promoter shares.

The top shareholders of Crestchem include Mr. Dipak Narendraprasad Patel, who holds the highest promoter stake at 28.94%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 66.63% of the shareholding. There are no institutional holdings from mutual funds or foreign institutional investors, and there are no pledged promoter holdings.

How big is Crestchem?

As of 24th July, Crestchem Ltd has a market capitalization of 49.00 Cr, with recent net sales of 25.08 Cr and a net profit of 2.73 Cr. The balance sheet for March 2024 shows shareholder's funds of 4.90 Cr and total assets of 7.13 Cr.

As of 24th July, Crestchem Ltd has a market capitalization of 49.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Crestchem reported Net Sales of 25.08 Cr and a Net Profit of 2.73 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 4.90 Cr and Total Assets of 7.13 Cr.

When is the next results date for Crestchem?

Crestchem is scheduled to declare its results on 12 November 2025.

Crestchem is scheduled to declare its results on 12 November 2025.

Are Crestchem latest results good or bad?

Crestchem's latest results show a mixed outlook; while there was a sequential improvement in revenue (up 42.94%) and net profit (up 54.29%), year-on-year comparisons reveal a decline in both metrics (revenue down 7.82% and net profit down 46.00%), alongside a significant drop in operating margin, indicating ongoing challenges for the company.

Crestchem's latest results present a mixed picture, leaning towards the negative side. While there was a notable sequential improvement in both revenue and net profit, with revenue increasing by 42.94% and net profit rising by 54.29% compared to the previous quarter, the year-on-year comparisons reveal significant challenges. Revenue has declined by 7.82% compared to the same quarter last year, and net profit is down 46.00% year-on-year. <BR><BR>Moreover, the operating margin has seen a substantial drop from 16.28% in the same quarter last year to just 8.48% now, indicating persistent margin pressures. This erosion in profitability metrics, coupled with a year-to-date stock decline of 56.19%, suggests that the company is struggling to regain its footing in a challenging operating environment.<BR><BR>Investors are currently cautious, weighing whether the recent uptick in volume and sequential growth can lead to a sustainable turnaround or if it is merely a temporary relief amidst ongoing operational difficulties. Overall, while there are signs of recovery, the underlying issues with profitability and market performance raise significant concerns.

How has been the historical performance of Crestchem?

Crestchem has shown significant growth in net sales and profitability, with net sales increasing from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, and profit after tax rising from 0.57 Cr to 2.73 Cr during the same period. The company's financial performance reflects strong operational efficiency and enhanced shareholder value.

Answer:<BR>The historical performance of Crestchem shows a significant upward trend in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Crestchem's net sales have increased from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25. The raw material costs also increased, from 5.82 Cr in Mar'21 to 18.76 Cr in Mar'25, indicating higher production expenses. Operating profit, excluding other income, improved from 0.65 Cr in Mar'21 to 3.28 Cr in Mar'25, while the overall operating profit rose from 0.70 Cr to 3.72 Cr during the same period. Profit before tax showed a notable increase from 0.67 Cr in Mar'21 to 3.66 Cr in Mar'25, leading to a profit after tax of 2.73 Cr in Mar'25, up from 0.57 Cr in Mar'21. The earnings per share also grew significantly from 1.9 in Mar'21 to 9.1 in Mar'25. On the balance sheet, total assets increased from 3.00 Cr in Mar'21 to 10.52 Cr in Mar'25, while total liabilities rose from 3.00 Cr to 10.52 Cr, with no long-term borrowings reported. The book value per share improved from 4.97 in Mar'21 to 24.92 in Mar'25, indicating enhanced shareholder value. Cash flow from operating activities turned positive in Mar'24 at 1.00 Cr and remained steady in Mar'25, showcasing improved operational efficiency. Overall, Crestchem's financial performance demonstrates robust growth and profitability over the years.

Should I buy, sell or hold Crestchem?

Is Crestchem overvalued or undervalued?

As of November 19, 2025, Crestchem is fairly valued with a PE ratio of 17.38 and has underperformed the Sensex with a year-to-date return of -58.22%, making it less attractive compared to peers like Godrej Industries and Solar Industries.

As of 19 November 2025, Crestchem's valuation grade has moved from very attractive to fair, indicating a shift in its market perception. The company is currently fairly valued, with a PE ratio of 17.38, an EV to EBITDA of 15.34, and a ROE of 25.03%. In comparison, peers such as Godrej Industries, which is rated attractive, has a significantly higher PE ratio of 37.28, while Solar Industries is deemed very expensive with a PE of 94.38.<BR><BR>Despite the fair valuation, Crestchem has underperformed relative to the Sensex, with a year-to-date return of -58.22% compared to the Sensex's 9.02%. This underperformance, coupled with its current ratios, suggests that while Crestchem may not be undervalued, it is not positioned as a strong investment compared to its peers in the specialty chemicals sector.

Which are the latest news on Crestchem?

Why is Crestchem falling/rising?

As of 03-Dec, Crestchem Ltd's stock price is Rs 117.00, down 2.38%, with significant declines over the past week (3.31%) and month (7.33%). The stock has fallen 58.22% year-to-date, underperforming the Sensex, and is currently trading below all major moving averages, indicating a bearish trend.

As of 03-Dec, Crestchem Ltd's stock price is falling, currently at Rs 117.00, which reflects a decrease of Rs 2.85 or 2.38%. The stock has underperformed against the sector by 1.09% today and has experienced a significant intraday low of Rs 110.9, marking a decline of 7.47%. <BR><BR>Over the past week, the stock has declined by 3.31%, while it has seen a more substantial drop of 7.33% over the past month. Year-to-date, the stock has plummeted by 58.22%, contrasting sharply with the Sensex, which has risen by 8.92% during the same period. Furthermore, Crestchem's performance over the past year shows a decrease of 57.38%, again underperforming the Sensex, which has increased by 5.27%.<BR><BR>The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 73.7% compared to the 5-day average. This lack of interest from investors, combined with the stock's poor performance metrics, contributes to the ongoing decline in Crestchem's stock price.